Redmile Group, LLC Absci Corp Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q3 2024
A detailed history of Redmile Group, LLC transactions in Absci Corp stock. As of the latest transaction made, Redmile Group, LLC holds 8,253,316 shares of ABSI stock, worth $22.1 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
8,253,316
Previous 8,253,316
-0.0%
Holding current value
$22.1 Million
Previous $25.4 Million
24.02%
% of portfolio
2.06%
Previous 1.66%
Shares
2 transactions
Others Institutions Holding ABSI
# of Institutions
127Shares Held
59.1MCall Options Held
255KPut Options Held
93.6K-
Fred Alger Management, LLC New York, NY7.57MShares$20.3 Million0.15% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.34MShares$17 Million0.23% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$14.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$13.2 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.62MShares$7.02 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $249M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....